ESENTRA 120MG INJECTION

Esentra 120mg Injection contains an active substance called Denosumab. It is a medicine for treating osteoporosis, characterized by weak bones. It is also used to avoid bone problems for those suffering from certain types of cancers, including bone metastases and myeloma. Esentra 120mg injection blocks a protein known as RANK, the ligand responsible for the degradation of bone tissue. Research has shown that it can boost bone density while reducing the risk of fractures in postmenopausal women who have osteoporosis, as well as patients suffering from the loss of bone due to cancer. A close monitoring of renal function is recommended for patients suffering from moderate impairment in their renal function.
Esentra 120mg Injection is not recommended to patients with known allergies or hypersensitivity with its constituents. Proper calcium and vitamin D supplement intake is essential to maintain the treatment. It is not suitable for use by young children or adolescents. The safety and effectiveness of the medication in the pediatric population have not been proven. Therefore, its use is not recommended for people under 18. This medication should be taken carefully for patients who have hypoparathyroidism, which is characterized by low levels of parathyroid hormone.